Evidence map›Paper›PMID 38017455›Full record

ArticleMalaria journal2023

Assessing the histidine-rich protein 2/3 gene deletion in Plasmodium falciparum isolates from Burkina Faso.

Casimire Wendlamita Tarama, Harouna Soré, Mafama Siribié, Siaka Débé, Réné Kinda, Wendyam Gérard Nonkani, Farida Tiendrebeogo, Winnie Bantango, Kassoum Yira, Esther Yéri Hien and 4 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Malaria diagnosis challenges andPathogens and global health · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Casimire Wendlamita TaramaCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Harouna SoréCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Mafama SiribiéCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Siaka DébéCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Réné KindaCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Wendyam Gérard NonkaniCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Farida TiendrebeogoCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Winnie BantangoCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Kassoum YiraCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Esther Yéri HienUniversité Joseph KI-ZERBO, Ouagadougou, Burkina Faso.
Moussa Wandaogo GuelbéogoCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Yves TraoréUniversité Joseph KI-ZERBO, Ouagadougou, Burkina Faso.
Didier Ménard *Institut Pasteur, Université Paris Cité, Malaria Genetic and Resistance Unit, INSERM U1201, 75015, Paris, France.
Adama Gansané *Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso. agansane@hotmail.com.
Centre National de Recherche et de Formation sur le Paludisme · BFUniversité Joseph Ki-Zerbo · BFUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDual hrp2/hrp3 genes deletions in P. falciparum isolates are increasingly reported in malaria-endemic countries and can produce false negative RDT results leading to inadequate case management. Data on the frequency of hrp2/hrp3 deleted parasites are rarely available and it has become necessary to investigate the issue in Burkina Faso.

methodsPlasmodium falciparum-positive dried blood spots were collected during a cross-sectional household survey of the malaria asymptomatic children from Orodara, Gaoua, and Banfora. Amplicons from the target regions (exon 2 of hrp2 and hrp3 genes) were generated using multiplexed nested PCR and sequenced according to Illumina's MiSeq protocol.

resultsA total of 251 microscopically positive parasite isolates were sequenced to detect hrp2 and hrp3 gene deletions. The proportion of RDTs negative cases among microscopy positive slides was 12.7% (32/251). The highest prevalence of negative RDTs was found in Orodara 14.3% (5/35), followed by Gaoua 13.1%(24/183), and Banfora 9.1% (3/33). The study found that 95.6% of the parasite isolates were wild type hrp2/ hrp3 while 4.4% (11/251) had a single hrp2 deletion. Of the 11 hrp2 deletion samples, 2 samples were RDT negative (mean parasitaemia was 83 parasites/ μL) while 9 samples were RDT positive with a mean parasitaemia of 520 parasites /μL (CI95%: 192-1239). The highest frequency of hrp2 deletion 4/35 (11.4%) was found in Orodara, while it was similar in the other two sites (< 3.5%). No single deletion of the hrp3 or dual deletion hrp2/3 gene was detected in this study.

conclusionThese results demonstrate that P. falciparum isolates lacking hrp2 genes are present in 4.4% of samples obtained from the asymptomatic children population in three sites in Burkina Faso. These parasites are circulating and causing malaria, but they are also still detectable by HRP2-based RTDs due to the presence of the intact pfhrp3 gene.

Indexed as

Malaria, FalciparumPlasmodium falciparumAntigens, ProtozoanBurkina FasoChildCross-Sectional StudiesDiagnostic Tests, RoutineGene DeletionHistidineHumansProtozoan ProteinsAntigens, ProtozoanHistidineProtozoan ProteinsBurkina Fasohrp2hrp3Malaria, Plasmodium falciparum

Identifiers

PMID38017455
PMCPMC10685617
OpenAlexW4389109332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.